We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

14 hedge funds and large institutions have $3.38M invested in AIM ImmunoTech in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 13 → 14 (+1)

7% less capital invested

Capital invested by funds: $3.63M → $3.38M (-$253K)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$111K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$74.3K
3
BIT
BlackRock Institutional Trust
California
+$24.8K
4
UBS Group
UBS Group
Switzerland
+$24.8K
5
VKH
Virtu KCG Holdings
New York
+$24.8K

Top Sellers

Rank Fund Capital Flow
1
AIG
American International Group
New York
-$66.1K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$12.4K
3
WS
Wedbush Securities
California
-$12.4K
4
Morgan Stanley
Morgan Stanley
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$1.18M +$24.8K +2 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.15M +$74.3K +6 +6%
OAM
3
Occidental Asset Management
California
$466K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$234K +$111K +9 +69%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$183K – – –
Northern Trust
6
Northern Trust
Illinois
$42K – – –
VKH
7
Virtu KCG Holdings
New York
$29K +$24.8K +2 +200%
UBS Group
8
UBS Group
Switzerland
$26K +$24.8K +2 New
State Street
9
State Street
Massachusetts
$16K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$14K -$12.4K -1 -50%
BA
11
BlackRock Advisors
Delaware
$14K +$12.4K +1 New
GC
12
Guggenheim Capital
Illinois
$8K – – –
WS
13
Wedbush Securities
California
$7K -$12.4K -1 -50%
Goldman Sachs
14
Goldman Sachs
New York
$6K +$12.4K +1 New
DC
15
Davenport & Co
Virginia
$2.04K – – –
BTS
16
BB&T Securities
Virginia
$2K – – –
ICAS
17
Investors Capital Advisory Services
Massachusetts
$2K – – –
Wells Fargo
18
Wells Fargo
California
$2K – – –
CHC
19
City Holding Co
West Virginia
$1K – – –
AIG
20
American International Group
New York
– -$66.1K -5 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$10K -1 Closed

AIM Hedge Fund Activity: Q2 2015 in Review

14 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2015, worth a combined $3.38M — down 7% from $3.63M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AIM positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $111K. The largest seller was American International Group, exiting entirely with an estimated $66.1K sold.

  • 14 institutional investors held AIM ImmunoTech (AIM) as of Q2 2015, up from 13 in Q1 2015.
  • Funds reported $3.38M of AIM ImmunoTech stock for Q2 2015, down 7% quarter-over-quarter.
  • 3 funds opened new AIM ImmunoTech positions in Q2 2015 and 2 closed out, a net change of +1 holder.
  • The largest AIM ImmunoTech buyer in Q2 2015 was Renaissance Technologies, an estimated $111K added.
  • The largest AIM ImmunoTech seller in Q2 2015 was American International Group, an estimated $66.1K sold.

Based on aggregated 13F filings for Q2 2015.